Hospitalization

COVID-19 vaccines remain effective against severe illness, hospitalization and death among U.S. adults, according to two studies published in Morbidity and Mortality Weekly Report.

For patients with type 2 diabetes and COVID-19, the risk for hospitalization increased with incrementally higher HbA1c levels, according to results of a large, multicenter cohort study.

Outcomes of early (within 24 hours) vs. late (more than 24 hours) presentation to the hospital in patients with non-STEMI.

COVID-19 hospitalization rates among children aged 0 to 4 years in the U.S. were around five times higher during the peak of the omicron wave compared with the peak of the delta wave, researchers reported in MMWR.

Infants of mothers who were vaccinated during pregnancy were less likely to be hospitalized with COVID-19, according to data published in MMWR.

Diabetic foot ulcer episodes were associated with all-cause mortality and all-cause inpatient hospital admissions, according to new results published in Diabetes Research and Clinical Practice.

Patients with schizophrenia who were treated with 3-monthly paliperidone in a clinical setting required rehospitalization less often, according to a 5-year U.K. mirror image study published in the Journal of Psychiatric Research.

Greater adiposity was associated with increased risk for hospital admission in the UK, and greater central adiposity increased risk more than higher BMI, according to findings published in Economics and Human Biology.

Data from Los Angeles County during the omicron surge showed that the COVID-19 hospitalization rate was 23 times higher among people who were unvaccinated compared with people who had received a COVID-19 vaccine series and booster.

Delayed presentation of 24 hours or more after non-STEMI symptom onset was associated with greater risk for all-cause death, recurrent MI and HF hospitalization compared with earlier presentation, researchers reported.